Biocatalysis for the synthesis of pharmaceuticals and pharmaceutical intermediates

H Sun, H Zhang, EL Ang, H Zhao�- Bioorganic & medicinal chemistry, 2018 - Elsevier
H Sun, H Zhang, EL Ang, H Zhao
Bioorganic & medicinal chemistry, 2018Elsevier
Biocatalysis has been increasingly used for pharmaceutical synthesis in an effort to make
manufacturing processes greener and more sustainable. Biocatalysts that possess excellent
activity, specificity, thermostability and solvent-tolerance are highly sought after to meet the
requirements of practical applications. Generating biocatalysts with these specific properties
can be achieved by either discovery of novel biocatalysts or protein engineering.
Meanwhile, chemoenzymatic routes have also been designed and developed for�…
Abstract
Biocatalysis has been increasingly used for pharmaceutical synthesis in an effort to make manufacturing processes greener and more sustainable. Biocatalysts that possess excellent activity, specificity, thermostability and solvent-tolerance are highly sought after to meet the requirements of practical applications. Generating biocatalysts with these specific properties can be achieved by either discovery of novel biocatalysts or protein engineering. Meanwhile, chemoenzymatic routes have also been designed and developed for pharmaceutical synthesis on an industrial scale. This review discusses the recent discoveries, engineering, and applications of biocatalysts for the synthesis of pharmaceuticals and pharmaceutical intermediates. Key classes of biocatalysts include reductases, oxidases, hydrolases, lyases, isomerases, and transaminases.
Elsevier